Growth Metrics

Fennec Pharmaceuticals (FENC) Assets Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 56.97%
Sep 30, 2025 -16.39%
Jun 30, 2025 -28.95%
Mar 31, 2025 -32.94%
Dec 31, 2024 67.31%
Sep 30, 2024 194.93%
Jun 30, 2024 224.95%
Mar 31, 2024 217.09%
Dec 31, 2023 -0.28%
Sep 30, 2023 -34.32%
Jun 30, 2023 24.85%
Mar 31, 2023 13.95%
Dec 31, 2022 20.19%
Sep 30, 2022 16.93%
Jun 30, 2022 -44.63%
Mar 31, 2022 -31.18%
Dec 31, 2021 -28.66%
Sep 30, 2021 -23.65%
Jun 30, 2021 -28.49%
Mar 31, 2021 168.37%
Dec 31, 2020 122.09%
Sep 30, 2020 114.18%
Jun 30, 2020 120.52%
Mar 31, 2020 -49.81%
Dec 31, 2019 -38.36%
Sep 30, 2019 -36.21%
Jun 30, 2019 -30.64%
Mar 31, 2019 -23.03%
Dec 31, 2018 -19.19%
Sep 30, 2018 152.17%
Jun 30, 2018 150.55%
Mar 31, 2018 716.18%
Dec 31, 2017 615.03%
Sep 30, 2017 115.90%
Jun 30, 2017 101.00%
Mar 31, 2017 459.18%
Dec 31, 2016 289.79%
Sep 30, 2016 215.86%
Jun 30, 2016 172.80%
Mar 31, 2016 -69.83%
Dec 31, 2015 -57.04%
Sep 30, 2015 115.45%
Jun 30, 2015 78.36%
Mar 31, 2015 39.71%
Dec 31, 2014 35.39%
Sep 30, 2014 5.16%
Jun 30, 2014 1.84%
Mar 31, 2014 -28.02%
Dec 31, 2013 -25.92%
Sep 30, 2013 -78.16%
Jun 30, 2013 -71.39%
Mar 31, 2013 -59.26%
Dec 31, 2012 -55.80%
Sep 30, 2012 -53.28%
Jun 30, 2012 -47.29%
Dec 31, 2011 -10.71%